Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. Whats new
Internal Medicine Journal, 09/01/09
Soulsby N et al. – Aminoglycoside dosing regimens have changed since the last survey was carried out in 1999. There has been an increase in the use of once–daily dosing from 54 to 88% of units. The reporting of both ototoxicity and renal toxicity has also increased (from 27 to 75% and from 19 to 65%, respectively). Standardization of management protocols for antibiotic use and patient monitoring may help reduce the risk of cumulative toxicity to aminoglycosides in CF patients.
Related Articles
Vitamin D supplementation for cystic fibrosis
Cochrane Reviews, 10/28/09
Relevance Score: 69%
Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09
Relevance Score: 69%
Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09
Relevance Score: 69%
Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09
Relevance Score: 69%
Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation
European Respiratory Journal, 10/23/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09
Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages
European Respiratory Journal , 11/25/09
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09
Today in Cystic Fibrosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis
European Respiratory Journal , 11/24/09
Continuous vs Thrice-Daily Ceftazidime for Elective Intravenous Antipseudomonal Therapy in Cystic Fibrosis
Infection, 09/22/09
Lung Transplantation in Patients with Cystic Fibrosis
Seminars in Respiratory and Critical Care Medicine, 09/17/09
Sponsor
Article Search
Sponsor


See Latest Articles


